DNA and its associated processes as targets for cancer therapy

Research output: Contribution to journalArticle

1006 Citations (Scopus)

Abstract

DNA is the molecular target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents. Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy. Furthermore, a new generation of agents that target DNA-associated processes are anticipated to be far more specific and effective. How have these agents evolved, and what are their molecular targets?

Original languageEnglish (US)
Pages (from-to)188-200
Number of pages13
JournalNature Reviews Cancer
Volume2
Issue number3
StatePublished - Mar 2002

Fingerprint

DNA
Cytotoxins
Neoplasms
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research

Cite this

DNA and its associated processes as targets for cancer therapy. / Hurley, Laurence.

In: Nature Reviews Cancer, Vol. 2, No. 3, 03.2002, p. 188-200.

Research output: Contribution to journalArticle

@article{ac2919ad2f7f446baa7d6a6408058024,
title = "DNA and its associated processes as targets for cancer therapy",
abstract = "DNA is the molecular target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents. Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy. Furthermore, a new generation of agents that target DNA-associated processes are anticipated to be far more specific and effective. How have these agents evolved, and what are their molecular targets?",
author = "Laurence Hurley",
year = "2002",
month = "3",
language = "English (US)",
volume = "2",
pages = "188--200",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - DNA and its associated processes as targets for cancer therapy

AU - Hurley, Laurence

PY - 2002/3

Y1 - 2002/3

N2 - DNA is the molecular target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents. Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy. Furthermore, a new generation of agents that target DNA-associated processes are anticipated to be far more specific and effective. How have these agents evolved, and what are their molecular targets?

AB - DNA is the molecular target for many of the drugs that are used in cancer therapeutics, and is viewed as a non-specific target of cytotoxic agents. Although this is true for traditional chemotherapeutics, other agents that were discovered more recently have shown enhanced efficacy. Furthermore, a new generation of agents that target DNA-associated processes are anticipated to be far more specific and effective. How have these agents evolved, and what are their molecular targets?

UR - http://www.scopus.com/inward/record.url?scp=0036519363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036519363&partnerID=8YFLogxK

M3 - Article

C2 - 11990855

AN - SCOPUS:0036519363

VL - 2

SP - 188

EP - 200

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 3

ER -